This HTML5 document contains 216 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37815613
rdf:type
wikibase:Item
schema:description
article científic vitskapeleg artikkel наукова стаття, опублікована в листопаді 2010 teaduslik artikkel επιστημονικό άρθρο 2010年學術文章 บทความทางวิทยาศาสตร์ wissenschaftlicher Artikel article scientific 2010年学术文章 artigo científico (publicado na 2010) articol științific videnskabelig artikel (udgivet 2010) мақолаи илмӣ 2010年の論文 научни чланак مقالهٔ علمی artykuł naukowy tudományos cikk artikulong pang-agham naučni članak 2010年學術文章 2010년 논문 ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vedecký článok научни чланак научна статия სამეცნიერო სტატია artículo científico publicado en 2010 2010年學術文章 2010年学术文章 2010年学术文章 мақолаи илмӣ գիտական հոդված artigo científico 2010年学术文章 vědecký článek 2010年学术文章 scienca artikolo mokslinis straipsnis article scientifique (publié 2010) bilimsel makale מאמר מדעי bài báo khoa học 2010年學術文章 vetenskaplig artikel 2010年學術文章 scientific article سائنسی مضمون artigo científico (publicado na 2010) مقالة علمية научная статья vitenskapelig artikkel 2010 nî lūn-bûn wetenschappelijk artikel artículu científicu espublizáu en 2010 artikull shkencor articolo scientifico 2010年學術文章 tieteellinen artikkeli
p:P577
wds:Q37815613-7AC1E9AD-16EE-487B-8417-768DD3FC0311
wdt:P577
2010-11-01T00:00:00Z
p:P2860
wds:Q37815613-CD43C85A-138A-450E-A174-DA0CBA15A7AD wds:Q37815613-CF2E8966-CEB1-42AF-B181-8730B5C092FC wds:Q37815613-DB792F2A-8F27-41EB-890E-49F88DC5076E wds:Q37815613-DD4B3A3F-E468-41FD-AE97-835FDEE37DA2 wds:Q37815613-E5DF0413-8C54-4654-896A-E1CC1CF89D5E wds:Q37815613-EA68BD65-4C01-4D17-8991-8AA329B1092A wds:Q37815613-EFD37F1A-F538-4769-9037-109DB820C60E wds:Q37815613-B9F844AC-075E-4EED-82F1-B9C78EA85EDE wds:Q37815613-BB206263-A364-4CB2-A289-23CEC63F7FEB wds:Q37815613-C39F6519-FD81-4B61-BA84-750AEAAE056F wds:Q37815613-CB80247D-2A14-4BA7-A0CD-F2482A4C3C12 wds:Q37815613-CBDD0835-457E-4BCD-8024-DD0E4FC77E4E wds:Q37815613-FF426C57-92E3-469D-BC0D-5B4F08A2C38F wds:Q37815613-64CF1E79-A058-424A-B84B-A60BD46F5B43 wds:Q37815613-67FD9235-EE44-4A71-B01A-629225017DD7 wds:Q37815613-71A095F4-F2F3-402A-BAEB-37CDABBA5252 wds:Q37815613-7E340FE7-6DD3-409E-AFEE-14514238D4DE wds:Q37815613-856FB24B-F06C-4FF9-84D9-1AADD8245032 wds:Q37815613-47049D07-EAA4-4586-A860-99669C78FBF4 wds:Q37815613-5BC6C4FE-A729-41F0-8B4D-E485296C7DF5 wds:Q37815613-5BEC43D6-6B9F-4B06-AE2C-5AB579D11EF2 wds:Q37815613-5C851C0E-1C06-40AC-B87E-BC5FF8424C99 wds:Q37815613-627FB258-3480-4078-938B-2B3E3CC0AEB9 wds:Q37815613-A2C8105B-5473-4495-9BAD-2DFCA3D26A71 wds:Q37815613-A5844444-2635-4828-B2D4-9662A18842A0 wds:Q37815613-A65A2ABE-1600-41E2-80D3-43CB9396975C wds:Q37815613-AD4EAF9E-1595-4445-ACE8-385CB799879A wds:Q37815613-B0F51723-54B6-49DB-868B-87E6D7D2DB63 wds:Q37815613-B68941EB-ABCA-4971-8087-B1CEA377526C wds:Q37815613-B8E5B864-F1B6-4338-9F41-858AC6E16A82 wds:Q37815613-8DB90AF7-500F-4714-A46B-6E2BE87C6984 wds:Q37815613-8EDB0E51-A9F9-4B80-B40E-F884CFB3707C wds:Q37815613-90BB79D3-EB7A-4326-8925-EDF1B8BBDC3D wds:Q37815613-98C7BA8C-B0D3-4EBB-A7A1-3E5B0DB2E9C9 wds:Q37815613-0115E13D-4B9D-416B-AD14-37A2B7EBF197 wds:Q37815613-061BF56F-3BC5-4296-8BE5-88CEEC9A4644 wds:Q37815613-0D613585-3FED-4228-B7FF-A516D8FB4BD1 wds:Q37815613-31CBEBDB-65F4-4DD2-A5EA-86DFDE27E81E wds:Q37815613-3666FE8F-3BC5-4D03-8A75-B207EC7ECF57 wds:Q37815613-39AF533D-FF07-4616-9884-0F5429372E9A wds:Q37815613-3F9BF3A8-67AC-4284-961D-F852CA9DD654 wds:Q37815613-4150A404-DEF7-4EEB-8652-5F7D8DF33ED2 wds:Q37815613-44EA5310-D0FB-4366-B3DE-6B5A04AC34D3 wds:Q37815613-0D8AD355-B1A7-44F0-8A70-49F442B05882 wds:Q37815613-10D91573-3742-4046-A0D7-5D556743C240 wds:Q37815613-15F14040-EF8E-44CF-8195-84461EB14BA8 wds:Q37815613-1F618EA1-0EBC-4CEE-8CC7-159552ABFF71 wds:Q37815613-20C33086-7AD0-4D3D-ADDA-BEB0A39ED5BF wds:Q37815613-257C5A1F-99D2-4EE6-8D84-E255707704F3
wdt:P2860
wd:Q67510949 wd:Q28308193 wd:Q40771097 wd:Q27824867 wd:Q27851414 wd:Q28271324 wd:Q27824819 wd:Q35810657 wd:Q27851456 wd:Q27851465 wd:Q44093928 wd:Q38584695 wd:Q38934630 wd:Q57758554 wd:Q51597972 wd:Q28281200 wd:Q37378581 wd:Q28348036 wd:Q28131776 wd:Q28305293 wd:Q36611365 wd:Q80704669 wd:Q38420145 wd:Q33359798 wd:Q27860884 wd:Q36094328 wd:Q95790587 wd:Q37330719 wd:Q21142734 wd:Q37759934 wd:Q27860562 wd:Q37687024 wd:Q29616397 wd:Q34554584 wd:Q46034442 wd:Q51717752 wd:Q46596767 wd:Q34318634 wd:Q37152445 wd:Q34096763 wd:Q34378885 wd:Q73295499 wd:Q27824850 wd:Q35876412 wd:Q37287501 wd:Q27851454 wd:Q47604705 wd:Q28240089 wd:Q55043614
p:P2093
wds:Q37815613-95677635-6EB3-4829-B40A-323ADA9D84F9 wds:Q37815613-747750A7-1D8C-43D7-B7CF-5E0F78906325 wds:Q37815613-4E0083F9-D6D8-4735-A4B1-C972C9C6D9FF wds:Q37815613-51C31790-0B09-469F-A9B9-8BCF158BC298 wds:Q37815613-4BD6B62A-2F03-403E-9229-01D69B2E1D7C wds:Q37815613-406D5452-F2B1-4239-B92E-0F410FA33038
wdt:P2093
Fabio Fulfaro Giuseppe Bronte Antonio Russo Sergio Rizzo Lidia Corsini Nicola Gebbia
rdfs:label
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
skos:prefLabel
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
schema:name
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
p:P50
wds:Q37815613-80322829-8DA0-4382-9BAF-69827C10EBD3 wds:Q37815613-1C39597E-9EFE-4657-8CD7-53984C35030F wds:Q37815613-0FDE9425-B07B-4844-8ABB-C17BDEF34485 wds:Q37815613-332C31D3-FF83-4423-B643-29C75E14C760 wds:Q37815613-FAF0F69D-17B7-469F-8B40-A2A19FCB3325
wdt:P50
wd:Q37837911 wd:Q87916808 wd:Q101974475 wd:Q37837892 wd:Q37837927
p:P1476
wds:Q37815613-9100352F-E047-41F2-9CB0-75E190AA6876
wdt:P1476
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
p:P304
wds:Q37815613-02E738BF-7E97-4DEE-B0B8-4773AAC13A6C
wdt:P304
S56-61
p:P31
wds:Q37815613-fdb250ae-b056-4f81-9cbd-2c4f316eaf18 wds:Q37815613-8DA20599-8CA9-4B13-9A6E-3DC75273CE00
wdt:P31
wd:Q7318358 wd:Q13442814
p:P921
wds:Q37815613-AFA5DF11-9584-4BD6-A087-A67556C363B8 wds:Q37815613-BB6AF37A-0D4C-419E-BF00-17681A645BEE wds:Q37815613-EC4EAF2A-938C-46CC-BF17-ED88E8EF4A8C
wdt:P921
wd:Q864574 wd:Q25493920 wd:Q188874
p:P698
wds:Q37815613-072DF69A-93FE-414E-861A-52EE484A66A6
wdtn:P698
n11:21129611
wdt:P698
21129611
p:P1433
wds:Q37815613-8909ABFA-975B-4433-9260-3CF9E9F95F9B
wdt:P1433
wd:Q1955762
p:P478
wds:Q37815613-BCCF9EF7-DEB1-4C1B-B71F-43D9AC9DD0A8
wdt:P478
36 Suppl 3
p:P356
wds:Q37815613-B9B89BDF-0710-4A14-8E43-F07D4548A60D
wdtn:P356
n10:S0305-7372(10)70021-9
wdt:P356
10.1016/S0305-7372(10)70021-9